Wildcat Capital Management’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Wildcat Capital Management’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-36,847	Closed	-$412K	–	32
2022 Q4	$412K	Hold	36,847	–	–	0.16%	24
2022 Q3	$207K	Hold	36,847	–	–	0.08%	27
2022 Q2	$160K	Hold	36,847	–	–	0.05%	24
2022 Q1	$429K	Hold	36,847	–	–	0.11%	21
2021 Q4	$673K	Hold	36,847	–	–	0.11%	21
2021 Q3	$437K	Hold	36,847	–	–	0.06%	25
2021 Q2	$633K	Buy	36,847 +545	+2%	+$10.4K	0.07%	20
2021 Q1	$664K	Hold	36,302	–	–	0.08%	24
2020 Q4	$683K	Hold	36,302	–	–	0.09%	20
2020 Q3	$766K	Hold	36,302	–	–	0.24%	19
2020 Q2	$1.05M	Buy	+36,302	New	+$1.09M	0.36%	19

Other funds holding OYST

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Wildcat Capital Management's OYST Position: Q1 2023 in Review

Wildcat Capital Management sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2023, closing a stake of 36,847 shares — an estimated $412K sold.

Wildcat Capital Management first reported a position in OYST in Q2 2020 and held it in 11 quarters. The position peaked at $1.05M in Q2 2020. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2023.

Wildcat Capital Management reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Wildcat Capital Management sold 36,847 Oyster Point Pharma, Inc. Common Stock shares in Q1 2023, an estimated $412K.
Wildcat Capital Management first reported a position in Oyster Point Pharma, Inc. Common Stock in Q2 2020 and held it in 11 quarters.
Wildcat Capital Management's Oyster Point Pharma, Inc. Common Stock position peaked at $1.05M in Q2 2020.
1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2023.

Based on Wildcat Capital Management's 13F filing for Q1 2023, filed 12 May 2023.